Efficacité après 5 ans d'un projet d'accès à la thérapie antirétrovirale en RDC

REFERENCES BIBLIOGRAPHIQUES

(1) ONUSIDA. Rapport sur l'épidémie mondiale de sida 2008. Disponible sur http://www.unaids.org/fr/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp [Consulté le 28 juin 2009].

(2) OMS. Traitement antirétroviral de l'infection à VIH chez l'adulte et l'adolescent en situation de ressources limitées. Disponible sur http://www.who.int/hiv/pub/arv/adult/fr/index.html [Consulté le 28 juin 2009].

(3) OMS, ONUSIDA, UNICEF. Vers un accès universel. Etendre les interventions les interventions prioritaires liées au VIH/SIDA dans le domaine de la santé. Rapport de situation 2008. Disponible sur http://whqlibdoc.who.int/publications/2008/9789242596885_fre.pdf [Consulté le 28 juin 2009].

(4) Lohse N, Hansen AB, Gerstoft J, Obel N. Improved survival in HIV-infected persons: consequences and perspectives. J Antimicrob Chemother. 2007;60:461-3.

(5) Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sorensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146:87-95.

(6) Etard JF, Ndiaye I, Thierry-Mieg M, Gueye NF, Gueye PM, Laniece I, et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS. 2006;20:1181-9.

(7) Bong CN, Yu JK, Chiang HC, Huang WL, Hsieh TC, Schouten EJ, et al. Risk factors for early mortality in children on adult fixed-dose combination antiretroviral treatment in a central hospital in Malawi. AIDS. 2007;21:1805-10.

(8) Brinkhof MW, Dabis F, Myer L, Bangsberg DR, Boulle A, Nash D, et al. Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries. Bull World Health Organ. 2008;86:559-67.

(9) Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, et al. Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med. 2009;6:e1000066

(10) Brinkhof MW, Pujades-Rodriguez M, Egger M. Mortality of patients lost to follow-up in antiretroviral treatment programmes in resource-limited settings: systematic review and meta-analysis. PLoS ONE 2009;4:e5790.

(11) Bussmann H, Wester CW, Ndwapi N, Grundmann N, Gaolathe T, Puvimanasinghe J, et al. Five-year outcomes of initial patients treated in Botswana's National Antiretroviral Treatment Program. AIDS. 2008;22:2303-11.

(12) Van der Borght SF, Clevenbergh P, Rijckborst H, Nsalou P, Onyia N, Lange JM.et al. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of multicountry HIV workplace programme in Africa. Antiviral therapy.2009.14:63-74.

(13) Coetzee D, Hildebrand K, Boulle A, Maartens G, Louis F, Labatala V, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS. 2004;18:887-95.

(14) Culbert H, Tu D, O'Brien DP, Ellman T, Mills C, Ford N, et al. HIV treatment in a conflict setting: outcomes and experiences from Bukavu, Democratic Republic of the Congo. PLoS Med. 2007;4:e129.

(15) Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006;367:1335-42.

(16) Jerene D, Endale A, Hailu Y, Lindtjorn B. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis. 2006;6:136.

(17) Johannessen A, Naman E, Ngowi BJ, Sandvik L, Matee MI, Aglen HE, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis. 2008;8:52.

(18) Karcher H, Omondi A, Odera J, Kunz A, Harms G. Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya. Trop Med Int Health. 2007;12:687-94.

(19) Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22:1897-908.

(20) O'Brien DP, Sauvageot D, Zachariah R, Humblet P. In resource-limited settings good early outcomes can be achieved in children using adult fixed-dose combination antiretroviral therapy. AIDS. 2006;20:1955-60.

(21) Sieleunou I, Souleymanou M, Schonenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2008;14:1-8.

(22) Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA .2006;296:782-93.

(23) van Griensven J, De Naeyer L, Uwera J, Asiimwe A, Gazille C, Reid T. Success with antiretroviral treatment for children in Kigali, Rwanda: experience with health center/nurse-based care. BMC Pediatr. 2008;8:39.

(24) Wamalwa DC, Farquhar C, Obimbo EM, Selig S, Mbori-Ngacha DA, Richardson BA, et al. Early response to highly active antiretroviral therapy in HIV-1-infected Kenyan children. J Acquir Immune Defic Syndr. 2007;45:311-7.

(25) Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, et al. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS. 2006;20:2355-60.

(26) Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med. 2007;4:e298.

(27) Bassett IV, Wang B, Chetty S, Mazibuko M, Bearnot B, Giddy J, et al. Loss to care and death before antiretroviral therapy in Durban, South Africa. J Acquir Immune Defic Syndr 2009 Jun 1;51(2):135-9.

(28) PNUD. Rapport national sur le développement humain 2008 en RDC. Disponible sur http://www.undp.org.cd/downloads/PNUD%20Rapport%20National%20sur%20le%20d%C3%A9veloppement%20Humain.pdf [Consulté le 28 juin 2009].

(29) OMS. Statistiques sanitaires mondiales 2009. Disponible sur
http://www.who.int/whosis/whostat/FR_WHS09_Full.pdf [Consulté le 28 juin 2009].

(30) MINISANTE RDC. Stratégie de renforcement du système de santé. Juin 2006.

(31) République Démocratique du Congo. Enquête Démographique et de 2007. Disponible sur http://www.measuredhs.com/pubs/pdf/FR208/FR208.pdf [Consulté le 28 juin 2009].

(32) Piot P, Quinn TC, Taelman H, Feinsod FM, Minlangu KB, Wobin O, et al. Acquired immunodeficiency syndrome in a heterosexual population in Zaire. Lancet.1984;2:65-9.

(33) MINISANTE RDC, OMS. Guide national de traitement de l'infection à VIH par les antirétroviraux. Janvier 2005.

(34) TranMinh T, Astel L, Chieze F, Mantion S, Adam G, Gentilini M. Dix ans de prise en charge du VIH/SIDA dans les centres de traitement ambulatoire de l'OPALS et de la croix rouge française. Med Trop. 2004. 64 :109-14.

(35) PNUD-FONDS MONDIAL. Evaluation de la prise en charge globale des personnes vivant avec le VIH sous ARV en République Démocratique du Congo. 2006.

(36) PNMLS/RDC. Rapport national de suivi UNGASS 2007. Disponible sur http://data.unaids.org/pub/Report/2008/democratic_republic_of_congo_2008_country_progress_report_fr.pdf [Consulté le 28 juin 2009].

(37) Janssens B, Raleigh B, Soeung S, Akao K, Te V, Gupta J, et al. Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia. Pediatrics. 2007;120:1134-40.

(38) Van Overloop C. Treatment outcomes of antiretroviral therapy in urban Kinshasa.
Thèse de maitrise. London School of Hygiene and Tropical Medecine. Année académique 2005-2006.

(39) OMS. ONUSIDA. Guide du conseil et du dépistage du VIH à l'initiative du soignant dans les établissements de santé. Disponible sur http://www.who.int/publications/list/9789241595568/fr/index.html [Consulté le 28 juin 2009].

(40) Weiser SD, Heisler M, Leiter K, Percy-de KF, Tlou S, DeMonner S, et al. Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3:e261.